Human herpesvirus 6: An evolving story

Herpes

Volumn 7, Issue 3, 2000, Pages 70-75

  Yamanishi, K ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

AIDS; Drug induced hypersensitivity; Exanthem subitum; Herpesvirus; Human herpesvirus 6 (HHV 6); Multiple sclerosis (MS); Roseola infantum; Transplantation

Indexed keywords

ACICLOVIR; BENZIMIDAZOLE DERIVATIVE; GUANINE DERIVATIVE; NUCLEOSIDE DERIVATIVE; PYROPHOSPHORIC ACID DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; ENCEPHALITIS; EXANTHEMA SUBITUM; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; IMMUNE DEFICIENCY; MULTIPLE SCLEROSIS; NOMENCLATURE; NONHUMAN; PERSISTENT VIRUS INFECTION; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; TAXONOMY; TRANSPLANTATION; ULTRASTRUCTURE; VIRUS DETECTION; VIRUS REACTIVATION; VIRUS TRANSMISSION;

EID: 0033753693     PISSN: 09697667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders
2. Human herpesvirus-6 (HHV-6)
3. HBLV (or HHV-6) in human cell lines
4. CD46 is a cellular receptor for human herpesvirus 6
5. Human herpesvirus 6
6. Human herpesvirus 6B genome sequence: Coding content and comparison with human herpesvirus 6A
7. The DNA sequence of human herpesvirus-6: Structure, coding content, and genome evolution
8. Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B
9. Identification of human herpesvirus-6 as a causal agent for exanthem subitum
10. Human herpesvirus 6
11. Viremia and neutralizing antibody response in infants with exanthem subitum
12. Identification of human herpesvirus 6 variants A and B by amplimer hybridization with variant-specific oligonucleotides and amplification with variant-specific primers
13. Differentiation between two distinct classes of viruses now classified as human herpesvirus 6
14. Variation of DNA sequence in immediate-early gene of human herpesvirus 6 and variant identification by PCR
15. Quantification of human herpesvirus 6 in immunocompetent persons and post-mortem tissues from AIDS patients by PCR
16. Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals
17. Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives
18. Detection of human herpesvirus-6 DNA in peripheral blood and saliva
19. Roseola infantum (exanthum subitum)
20. Studies on the etiology of exanthem subitum (roseola infantum)
21. Experimental inoculation of roseola infantum
22. Roseola infantilitis
23. Severity of human herpesvirus-6 viremia and clinical findings in infants with exanthem subitum
24. Brief report: Severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult
25. The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis- like illnesses not resulting from Epstein-Barr virus or cytomegalovirus
26. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation
27. Transient erythroblastopenia of childhood associated with human herpesvirus type 6, variant B
28. Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection
29. Human herpesvirus-6 infection with liver injury in neonatal hepatitis
30. Idiopathic thrombocyto penic purpura after human herpesvirus 6 infection
31. Outbreak of exanthem subitum in an orphanage
32. Human herpesvirus 6 infection of the female genital tract
33. Human herpesviruses 6 and 7 in cervixes of pregnant women
34. Primary infection of human herpesvirus 6 in children with vertical infection of human immunodeficiency virus type 1
35. Reactivation of human herpesvirus 6 during pregnancy
36. Congenital infections with human herpesvirus 6
37. Chromosomal transmission of human herpesvirus 6 DNA in acute lymphoblastic leukaemia
38. Integration of human herpesvirus 6 genome in human chromosomes
39. Direct sequence analysis of human herpesvirus 6 (HHV-6) sequences from infants and comparison of HHV-6 sequences from mother/infant pairs
40. Latent human herpesvirus 6 infection of human monocytes/macrophages
41. Neuroinvasion of human herpesvirus 6 and 7
42. Human herpesvirus 6 latently infects early bone marrow progenitors in vivo
43. In vitro activation of human herpesviruse: 6 and 7 from latency
44. Reactivation of human herpesvirus 6 by infection of human herpesvirus 7
45. Activatior of human herpesvirus-6 in children with acute measles
46. Human herpesvirus 6 infections after bone marrow transplantation: Clinical and virologic manifestations
47. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: Evidence of a marrow-suppressive role for HHV-6 in vivo
48. Brief report: Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow transplant recipient
49. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation
50. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation
51. Human herpes virus-6 infection in marrow graft recipients: Role in pathogenesis of graft-versus-host disease. Bone Marrow Transport Group
52. Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation
53. Human herpesvirus 6 infection in renal transplantation
54. 'Cytomegalovirus disease' in renal allograft recipients: Is human herpesvirus 7 a co-factor for disease progression?
55. Human herpesvirus-6 infection in liver transplant recipients: Documentation of pathogenicity
56. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: Prospective comparison with the effect of cytomegalovirus
57. Disseminated active HHV-6 infections in patients with AIDS
58. Human herpesvirus 6 in AIDS
59. Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture
60. Interactions between beta-herpesvirus and human immunodeficiency virus in vivo: Evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6
61. Modulation of CD4, CXCR-4, and CCR-5 makes human hematopoietic progenitor cell lines infected with human herpesvirus-6 susceptible to human immunodeficiency virus type 1
62. Serum IgG antibodies to human herpesvirus-6 (HHV-6) do not predict the progression of HIV disease to AIDS. Italian Seroconversion Study group
63. Human herpesvirus 6 and multiple sclerosis
64. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis
65. Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis
66. Leukotropic herpesviruses in multiple sclerosis
67. Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients
68. A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients
69. Detection of human herpesvirus 6 variant A in peripheral blood mononuclear cells from multiple sclerosis patients
70. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients
71. Increased lympho-proliferative response to human herpesvirus type 6 A variant in multiple sclerosis patients
72. The association of the human herpevirus-6 and MS
73. The HHV6 paradox: Ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach
74. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrom
75. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6
76. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis
77. A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs
78. Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study
79. Isolation of a new herpesvirus from human CD4+ T cells
80. Human herpevirus-6 strain groups; a nomenclature